If there's a diet, Janet McCaskill says, she's done it ... and they're likely not going to be able to afford the FDA-approved ...

The prescription drug has been all over the news in the past couple of years - but the name Ozempic has become something of a ...

The U.S. Food and Drug Administration (FDA) has approved flurpiridaz F-18 (Flyrcado; GE Healthcare), a first-of-its-kind positron emission tomography (PET) imaging agent, for use in adult patients ...

Ten years after first collecting an FDA approval, it’s time for version number two. Exact Sciences has received an agency green light for Cologuard Plus, the next generation of its mainstay ...

The Food and Drug Administration (FDA) last week approved Bristol Myers Squibb’s antipsychotic drug Cobenfy (xanomeline and trospium chloride), the first schizophrenia treatment with an entirely new ...

The U.S. Food and Drug Administration (FDA) has approved flurpiridaz F-18 (Flyrcado; GE Healthcare), a first-of-its-kind positron emission tomography (PET) imaging agent, for use in adult patients ...

The poisonous flower yellow oleander is showing up in diet ... Drug Administration. Consuming yellow oleander can cause heart and brain problems that can be severe or even deadly. The FDA said ...

A new drug has been approved for the treatment of schizophrenia in adults. On Thursday, the U.S. Food and Drug Administration (FDA) approved COBENFY (xanomeline and trospium chloride), an oral ...

The US FDA has approved Bristol ... beginning with today’s approval for schizophrenia.” Bristol Myers Squibb plans to make Cobenfy, a twice-daily pill, available by late October.

People with schizophrenia will have a new treatment option for the first time in more than three decades, after the Food and Drug Administration Thursday approved a new kind of drug. Studies ...

That aside, it is the most exciting development in many years.” Prof Matt Jones, Professor of Neuroscience at the University of Bristol, said: “This new drug promises effective treatment but – ...